Breaking News, Promotions & Moves

KCAS

Proveen Dass, Ph.D., has been appointed associate director of KCAS, Inc. He joins Masood Khan, Ph.D., senior director of immunoanalytical science and technology, and his ligand binding assay (LBA) team.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Proveen Dass, Ph.D., has been appointed associate director of KCAS, Inc. He joins Masood Khan, Ph.D., senior director of immunoanalytical science and technology, and his ligand binding assay (LBA) team. Dr. Dass will use his industry experience to assist Dr. Khan with the development of GLP-compliant and non-GLP assays for the large molecule bioanalytical studies, including PK/TK analysis, immunogenicity evaluation and biomarker quantification. KCAS uses immunoanalytical technologies to supp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters